Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $38,153 | 9 | 81.1% |
| Travel and Lodging | $7,566 | 26 | 16.1% |
| Food and Beverage | $1,297 | 30 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $35,106 | 51 | $0 (2018) |
| Gilead Sciences Inc | $6,842 | 11 | $0 (2017) |
| ViiV Healthcare Company | $4,080 | 2 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $987.50 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $11,672 | 17 | Merck Sharp & Dohme Corporation ($11,672) |
| 2017 | $35,344 | 48 | Merck Sharp & Dohme Corporation ($23,434) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2018 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/26/2018 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $4,675.00 | General |
| 06/26/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 06/25/2018 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $4,675.00 | General |
| 06/25/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 06/15/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $76.31 | General |
| 06/15/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $49.80 | General |
| 06/15/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 06/15/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $34.97 | General |
| 06/14/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $588.98 | General |
| 06/14/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $266.48 | General |
| 06/08/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $248.07 | General |
| 06/08/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 06/08/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 06/08/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 06/07/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $341.20 | General |
| 06/07/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $237.63 | General |
| 09/01/2017 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $6,800.00 | General |
| 09/01/2017 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 09/01/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $29.48 | General |
| 09/01/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $24.04 | General |
| 09/01/2017 | Gilead Sciences Inc | — | Travel and Lodging | In-kind items and services | $17.00 | General |
| 08/11/2017 | Gilead Sciences Inc | — | Consulting Fee | Cash or cash equivalent | $4,020.00 | General |
| 08/11/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 08/11/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $50.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 87 | 121 | $25,151 | $6,970 |
| 2022 | 2 | 103 | 123 | $16,928 | $4,839 |
| 2021 | 5 | 92 | 133 | $31,383 | $9,209 |
| 2020 | 5 | 102 | 127 | $24,686 | $6,085 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 54 | $13,284 | $3,887 | 29.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 22 | $6,534 | $1,875 | 28.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 22 | $4,620 | $1,014 | 22.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 23 | 23 | $713.00 | $193.20 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 61 | $15,006 | $4,656 | 31.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 55 | 62 | $1,922 | $182.58 | 9.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 64 | $15,744 | $4,800 | 30.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 15 | 15 | $5,055 | $1,599 | 31.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 16 | 26 | $5,460 | $1,479 | 27.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 16 | $4,752 | $1,295 | 27.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 11 | 12 | $372.00 | $36.00 | 9.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 54 | 79 | $19,334 | $4,320 | 22.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 12 | 12 | $4,044 | $1,306 | 32.3% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 12 | 12 | $360.00 | $234.96 | 65.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 12 | 12 | $576.00 | $187.32 | 32.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 12 | 12 | $372.00 | $35.82 | 9.6% |
About Dr. Michael Saag, MD
Dr. Michael Saag, MD is a Infectious Disease healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700809548.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Saag, MD has received a total of $47,016 in payments from pharmaceutical and medical device companies, with $11,672 received in 2018. These payments were reported across 65 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($38,153).
As a Medicare-enrolled provider, Saag has provided services to 384 Medicare beneficiaries, totaling 504 services with total Medicare billing of $27,102. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Birmingham, AL
- Active Since 07/25/2006
- Last Updated 06/29/2023
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1700809548
Products in Payments
- TRIZIVIR (Drug) $4,080
- SUSTIVA (Drug) $987.50
- ISENTRESS (Drug) $13.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Birmingham
Sonya Heath
Infectious Disease — Payments: $103,197
John Baddley, Md, MD
Infectious Disease — Payments: $101,314
Christina Muzny
Infectious Disease — Payments: $87,717
Edgar Overton
Infectious Disease — Payments: $78,314
Peter Pappas
Infectious Disease — Payments: $73,326
William Geisler, Md, MD
Infectious Disease — Payments: $66,779